Hindman Andrew A.
- SEC CIK
- 0001607965
No open-market purchases or sales filed in the past year.
Current role at each company
- TBPH Theravance Biopharma, Inc.SVP, CHIEF FINANCIAL OFFICERas of Nov 22, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Hindman Andrew A. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 22, 2022 (view filing) | Nov 18 | 4 days | Hindman Andrew A.SVP, CHIEF FINANCIAL OFFICER | SSale | −65.0K | $11.02 | −$716.3K | −13.7%409.8K after |